SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
45 hedge funds and large institutions have $62.3M invested in Sinovac Biotech, Ltd in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Holders
45
Holding in Top 10
–
Calls
$65K
Puts
$150K
Top Buyers
| 1 | +$5.69M | |
| 2 | +$4.39M | |
| 3 | +$1.51M | |
| 4 |
Morgan Stanley
New York
|
+$456K |
| 5 |
Renaissance Technologies
New York
|
+$438K |
Top Sellers
| 1 | -$7.05M | |
| 2 | -$5.64M | |
| 3 | -$1.65M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$771K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$259K |